Moderna said it intends to keep its COVID-19 vaccine on the market for free to consumers, even after the U.S. government stops paying for it, ABC News’ Anne Flaherty reports. "Everyone in the United States will have access to Moderna’s COVID-19 vaccine regardless of their ability to pay," the company said in a statement, according to ABC News. Reference Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MRNA:
- Sanders calls Moderna chief to testify on vaccine price hike plans, WP says
- Model N price target raised to $52 from $45 at Truist
- Catalent price target raised to $82 from $75 at Baird
- Personalis upgraded to Buy at Needham on cost reductions, biopharma potential
- Personalis, Moderna announce new agreement to leverage NeXT Platform